SCHEMBL13014207

SCHEMBL13014207

CN1Cc2nc3c(c(-c4ccccc4)c2C1=O)c(=O)[nH]c(=O)n3-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.35
MAPKAPK2 P49137 1/20 0.35
TSHR P16473 2/20 0.34
ROCK2 O75116 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
MAP3K11 Q16584 2/20 0.34
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
CSNK2A1 P68400 2/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13012934 0.84 KMT2A (0.34) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL13013572 0.80 KMT2A (0.37) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL13014413 0.68 ALDH1A1 (0.57) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL22093132 0.61 MAT2A (0.57) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL31145399 0.61 MAT2A (0.57) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL22094062 0.61 MAP3K11 (0.45) LMNAKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL5437607 0.60 KDM4E (0.46) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL6314968 0.60 DHFR (0.46) LMNAKMT2AMEN1NPC1RAB9A
SCHEMBL3554510 0.60 CSNK2A1 (0.43) LMNAKMT2AMEN1SMN1; SMN2TP53
SCHEMBL22103484 0.60 MAP3K11 (0.41) LMNAKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010149786-A1 PYRIDO [2, 3-D] PYRIMIDINES AS WNT ANTAGONISTS FOR TREATMENT OF CANCER AND ARTHRITIS DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2010-12-29 WO disclosed